Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome.

Journal of neuro-oncology - 1 Sept 2011

Sjöström S, Wibom C, Andersson U, Brännström T, Broholm H, Johansen C, Collatz-Laier H, Liu Y, Bondy M, Henriksson R, Melin B

Abstract excerpt

Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) are central components in the development and progression of glioblastoma. To investigate if genetic variation in VEGF and VEGFR2 is associated with glioblastoma prognosis, we examined blood samples from 154 glioblastoma cases collected in Sweden and Denmark between 2000 and 2004. Seventeen tagging single nucleotide polymorphisms (SNPs) in VEGF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Prognosis

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Vascular Endothelial Growth Factor A

Share to Vascular Endothelial Growth Factor Receptor-2

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 21191630
DOI: 10.1007/s11060-010-0504-2
PMCID: PMC3161189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome.PMID 21191630Read ↗

The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas.Semantic proximity Read ↗

Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas.Semantic proximity Read ↗

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.Semantic proximity Read ↗

The VEGF gene polymorphism in glioblastoma may be a new prognostic marker of overall survival.Semantic proximity Read ↗

VEGF gene polymorphisms in Iranian patients with intracranial glioblastoma.Semantic proximity Read ↗

Genetic variations in EGF and EGFR and glioblastoma outcome.Semantic proximity Read ↗

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.Semantic proximity Read ↗

Genetic Variants Impacting Angiogenesis Signaling Pathways in Glioblastoma Multiforme: A Systematic Review of Mutations and Polymorphisms.Semantic proximity Read ↗

Association of the VEGFR2 single nucleotide polymorphism rs2305948 with glioma risk.Semantic proximity Read ↗

The role of vascular endothelial growth factor genetic variability in cancer.Semantic proximity Read ↗

DNA-repair gene variants are associated with glioblastoma survival.Semantic proximity Read ↗

Association of single nucleotide variants in VEGFA and KDR with the risk and angiogenic features of diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.